A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Status:
Completed
Trial end date:
2019-08-28
Target enrollment:
Participant gender:
Summary
This study will assess the potential for clinical drug-drug interactions between
omaveloxolone and a number of substrates and inhibitors of metabolic enzymes and drug
transporters.